"The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older.
ERYGEL® (erythromycin topical gel) Topical Gel is indicated for the topical treatment of acne vulgaris.
DOSAGE AND ADMINISTRATION
ERYGEL® (erythromycin topical gel) Topical Gel should be applied sparingly as a thin film to affected area(s) once or twice a day after the skin is thoroughly cleansed and patted dry. If there has been no improvement after 6 to 8 weeks, or if the condition becomes worse, treatment should be discontinued, and the physician should be reconsulted. Spread the medication lightly rather than rubbing it in. There are no data directly comparing the safety and efficacy of b.i.d. versus q.d. dosing.
ERYGEL® (Erythromycin Topical Gel USP) 2% is supplied in plastic tubes in the following sizes: 30 g - NDC 0023-4312-30 and 60 g - NDC 0023-4312-60.
Note: FLAMMABLE. Keep away from heat and flame. Store and dispense in original container. Keep tube tightly closed. Store between 15° and 25°C (59° and 77°F).
Distributed by: Merz Pharmaceuticals, Greensboro, NC 27410. Rev 1/00. FDA revision date: 12/9/2002This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 3/30/2017
Additional Erygel Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.